Search Result "AG3340"
Application of Recombinant and Non-Recombinant Peptides in the Determination of Tumor Response to Cancer Therapy
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 2 Year: 2011 Page: 320-335
Author(s): Lluis A. Lopez-Barcons, Arif N. Ali, Roberto Diaz
Proteomic Validation of Protease Drug Targets: Pharmacoproteomics of Matrix Metalloproteinase Inhibitor Drugs Using Isotope-Coded Affinity Tag Labelling and Tandem Mass Spectrometry
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 263-270
Author(s): G. S. Butler, C. M. Overall
Matrixmetalloproteinase Inhibitors: Promising Therapeutic Targets Against Cancer
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 45 Year: 2021 Page: 4557-4567
Author(s): Vibha Rani,Dhananjay Yadav,Neha Atale
Antiangiogenic Therapy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 27-37
Author(s): Daniel Albo, Thomas N. Wang, George P. Tuszynski
Chemically Synthesized Matrix Metalloproteinase and Angiogenesis-inhibiting Peptides as Anticancer Agents
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 3 Year: 2014 Page: 483-494
Author(s): Jialiang Hu,Ming Yan,Chunyan Pu,Jingjing Wang,Philippe E. Van den Steen,Ghislain Opdenakker,Hanmei Xu
CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
Journal: Current Neurovascular Research
Volume: 6 Issue: 3 Year: 2009 Page: 140-147
Author(s): Yuichi Chikaraishi, Masamitsu Shimazawa, Koichi Yokota, Koichiro Yoshino, Hideaki Hara
Selectivity, Binding Affinity, and Ionization State of Matrix Metalloproteinase Inhibitors
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 26 Year: 2013 Page: 4701-4713
Author(s): Haizhen A. Zhong,Jack Arbiser,J. Phillip Bowen
Antineovascular Agents in the Treatment of Eye Diseases
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 2 Year: 2006 Page: 2645-2660
Author(s): Wolfram Eichler, Yousef Yafai, Peter Wiedemann, Dorte Fengler
MMPs in Ovarian Cancer as Therapeutic Targets
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 7 Year: 2012 Page: 764-772
Author(s): Amer Karam,Oliver Dorigo
Anti-Angiogenic Therapy in Renal Cell Carcinoma
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 77-83
Author(s): Shree G. Sharma, Sudip Nanda, Santo Longo